CLYM Reports $0 Revenue, $0 EPS, Updates Budoprutug Phase 1b/2a ITP Data H2 2026, CLYM116 Phase 1 Enrollment Ongoing, Cash Runway to 2028
Climb Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $11.80
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS